Lycopene Market by Form, (Powder and Others), Nature (Natural and Synthetic), and Application (Food and Beverage, Nutraceuticals and Pharmaceuticals, and Cosmetics and Personal Care): Global Opportunity Analysis and Industry Forecast, 2021–2030

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.4.Research methodology

1.4.1.Primary research

1.4.2.Secondary research

1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings

2.1.1.Top impacting factors

2.1.2.Top investment pockets

2.2.CXO perspective

2.3.View of Engaged Stakeholders

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Porter's five forces analysis

3.2.1.Bargaining power of suppliers

3.2.2.Bargaining power of buyers

3.2.3.Threat of substitution

3.2.4.Threat of new entrants

3.2.5.Intensity of competitive rivalry

3.3.Parent market overview

3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Use of lycopene as a natural coloring agent in food and beverages to drive the market growth

3.4.1.2.Various health benefits of lycopene to benefit the nutraceutical industry

3.4.1.3.Skin repairing and skin improving qualities of lycopene to increase its adoption in cosmetic industry

3.4.2.Restraints

3.4.2.1.Availability of several other sources for red food coloring to impede market growth

3.4.2.2.Low stability of lycopene to challenge market expansion

3.4.3.Opportunities

3.4.3.1.Increase in consumer demand for clean label products can help provide impetus to the market

3.4.3.2.Newer demand from the animal feed industry can help create new growth avenues

3.5.Industry life cycle assessment, by region

3.6.Geographical concentration analysis of lycopene producers

CHAPTER 4:GLOBAL LYCOPENE MARKET, BY FORM

4.1.Overview

4.1.1.Market size and forecast, by Form

4.2.Powder

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.3.Others

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast, by region

4.3.3.Market analysis, by country

CHAPTER 5:GLOBAL LYCOPENE MARKET, BY NATURE

5.1.Overview

5.1.1.Market size and forecast, by Nature

5.2.Natural

5.2.1.Key market trends, growth factors, and opportunities

5.2.2.Market size and forecast, by region

5.2.3.Market analysis, by country

5.3.Synthetic

5.3.1.Key market trends, growth factors, and opportunities

5.3.2.Market size and forecast, by region

5.3.3.Market analysis, by country

CHAPTER 6:GLOBAL LYCOPENE MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast, by Application

6.2.Food and Beverage

6.2.1.Key market trends, growth factors, and opportunities

6.2.2.Market size and forecast, by region

6.2.3.Market analysis, by country

6.3.Nutraceuticals and Pharmaceuticals

6.3.1.Key market trends, growth factors, and opportunities

6.3.2.Market size and forecast, by region

6.3.3.Market analysis, by country

6.4.Cosmetics and Personal Care

6.4.1.Key market trends, growth factors, and opportunities

6.4.2.Market size and forecast, by region

6.4.3.Market analysis, by country

CHAPTER 7:LYCOPENE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast, by region

7.2.North America

7.2.1.Overview

7.2.2.Key market trends, growth factors, and opportunities

7.2.3.Market size and forecast, by Form

7.2.4.Market size and forecast, by Nature

7.2.5.Market size and forecast, by Application

7.2.6.Market analysis, by Country

7.2.6.1.U.S.

7.2.6.1.1.Market size and forecast, by Form

7.2.6.1.2.Market size and forecast, by Nature

7.2.6.1.3.Market size and forecast, by Application

7.2.6.2.Canada

7.2.6.2.1.Market size and forecast, by Form

7.2.6.2.2.Market size and forecast, by Nature

7.2.6.2.3.Market size and forecast, by Application

7.2.6.3.Mexico

7.2.6.3.1.Market size and forecast, by Form

7.2.6.3.2.Market size and forecast, by Nature

7.2.6.3.3.Market size and forecast, by Application

7.3.Europe

7.3.1.Overview

7.3.2.Key market trends, growth factors, and opportunities

7.3.3.Market size and forecast, by Form

7.3.4.Market size and forecast, by Nature

7.3.5.Market size and forecast, by Application

7.3.6.Market analysis, by Country

7.3.6.1.UK

7.3.6.1.1.Market size and forecast, by Form

7.3.6.1.2.Market size and forecast, by Nature

7.3.6.1.3.Market size and forecast, by Application

7.3.6.2.Germany

7.3.6.2.1.Market size and forecast, by Form

7.3.6.2.2.Market size and forecast, by Nature

7.3.6.2.3.Market size and forecast, by Application

7.3.6.3.France

7.3.6.3.1.Market size and forecast, by Form

7.3.6.3.2.Market size and forecast, by Nature

7.3.6.3.3.Market size and forecast, by Application

7.3.6.4.Italy

7.3.6.4.1.Market size and forecast, by Form

7.3.6.4.2.Market size and forecast, by Nature

7.3.6.4.3.Market size and forecast, by Application

7.3.6.5.Spain

7.3.6.5.1.Market size and forecast, by Form

7.3.6.5.2.Market size and forecast, by Nature

7.3.6.5.3.Market size and forecast, by Application

7.3.6.6.Rest of Europe

7.3.6.6.1.Market size and forecast, by Form

7.3.6.6.2.Market size and forecast, by Nature

7.3.6.6.3.Market size and forecast, by Application

7.4.Asia-Pacific

7.4.1.Overview

7.4.2.Key market trends, growth factors, and opportunities

7.4.3.Market size and forecast, by Form

7.4.4.Market size and forecast, by Nature

7.4.5.Market size and forecast, by Application

7.4.6.Market analysis, by country

7.4.6.1.China

7.4.6.1.1.Market size and forecast, by Form

7.4.6.1.2.Market size and forecast, by Nature

7.4.6.1.3.Market size and forecast, by Application

7.4.6.2.Japan

7.4.6.2.1.Market size and forecast, by Form

7.4.6.2.2.Market size and forecast, by Nature

7.4.6.2.3.Market size and forecast, by Application

7.4.6.3.India

7.4.6.3.1.Market size and forecast, by Form

7.4.6.3.2.Market size and forecast, by Nature

7.4.6.3.3.Market size and forecast, by Application

7.4.6.4.ASEAN

7.4.6.4.1.Market size and forecast, by Form

7.4.6.4.2.Market size and forecast, by Nature

7.4.6.4.3.Market size and forecast, by Application

7.4.6.5.Australia

7.4.6.5.1.Market size and forecast, by Form

7.4.6.5.2.Market size and forecast, by Nature

7.4.6.5.3.Market size and forecast, by Application

7.4.6.6.South Korea

7.4.6.6.1.Market size and forecast, by Form

7.4.6.6.2.Market size and forecast, by Nature

7.4.6.6.3.Market size and forecast, by Application

7.4.6.7.Rest of Asia-Pacific

7.4.6.7.1.Market size and forecast, by Form

7.4.6.7.2.Market size and forecast, by Nature

7.4.6.7.3.Market size and forecast, by Application

7.5.LAMEA

7.5.1.Overview

7.5.2.Key market trends, growth factors, and opportunities

7.5.3.Market size and forecast, by Form

7.5.4.Market size and forecast, by Nature

7.5.5.Market size and forecast, by Application

7.5.6.Market analysis, by country

7.5.6.1.Brazil

7.5.6.1.1.Market size and forecast, by Form

7.5.6.1.2.Market size and forecast, by Nature

7.5.6.1.3.Market size and forecast, by Application

7.5.6.2.Argentina

7.5.6.2.1.Market size and forecast, by Form

7.5.6.2.2.Market size and forecast, by Nature

7.5.6.2.3.Market size and forecast, by Application

7.5.6.3.Saudi Arabia

7.5.6.3.1.Market size and forecast, by Form

7.5.6.3.2.Market size and forecast, by Nature

7.5.6.3.3.Market size and forecast, by Application

7.5.6.4.South Africa

7.5.6.4.1.Market size and forecast, by Form

7.5.6.4.2.Market size and forecast, by Nature

7.5.6.4.3.Market size and forecast, by Application

7.5.6.5.Rest of LAMEA

7.5.6.5.1.Market size and forecast, by Form

7.5.6.5.2.Market size and forecast, by Nature

7.5.6.5.3.Market size and forecast, by Application

CHAPTER 8:COMPETITION LANDSCAPE

8.1.Overview

8.2.Competitive dashboard

8.3.Competitive heat map

8.4.Product mapping

8.5.Top winning strategies

8.6.Key developments

8.6.1.Acquisition

8.6.2.Business Expansion

8.6.3.Product Launch

8.6.4.Partnership

8.6.5.Agreement

8.6.6.Collaboration

8.6.7.Joint venture

8.6.8.Merger

8.7.Top Player Positioning

CHAPTER 9:COMPANY PROFILE

9.1.ALLIED BIOTECH CORPORATION

9.1.1.Company overview

9.1.2.Company snapshot

9.1.3.Operating business segments

9.1.4.Product portfolio

9.2.ARCHER DANIELS MIDLAND COMPANY

9.2.1.Company overview

9.2.2.Key executive

9.2.3.Company snapshot

9.2.4.Operating business segments

9.2.5.Product portfolio

9.2.6.R&D expenditure

9.2.7.Business performance

9.2.8.Key strategic moves and developments

9.3.AROMATAGROUP SRL

9.3.1.Company overview

9.3.2.Key Executives

9.3.3.Company snapshot

9.3.4.Operating business segments

9.3.5.Product portfolio

9.3.6.Key strategic moves and developments

9.4.BASF SE

9.4.1.Company overview

9.4.2.Key Executives

9.4.3.Company snapshot

9.4.4.Operating business segments

9.4.5.Product portfolio

9.4.6.Business performance

9.4.7.Key strategic moves and developments

9.5.DIVIS LABORATORIES LTD.

9.5.1.Company overview

9.5.2.Key Executives

9.5.3.Company snapshot

9.5.4.Operating business segments

9.5.5.Product portfolio

9.5.6.Business performance

9.5.7.Key strategic moves and developments

9.6.DOEHLER GROUP SE

9.6.1.Company overview

9.6.2.Key Executives

9.6.3.Company snapshot

9.6.4.Operating business segments

9.6.5.Product portfolio

9.7.EXCELVITE

9.7.1.Company overview

9.7.2.Key Executives

9.7.3.Company snapshot

9.7.4.Operating business segments

9.7.5.Product portfolio

9.8.Givaudan International SA (NATUREX S.A.)

9.8.1.Company overview

9.8.2.Key executive

9.8.3.Company snapshot

9.8.4.Operating business segments

9.8.5.Product portfolio

9.8.6.R&D expenditure

9.8.7.Business performance

9.8.8.Key strategic moves and developments

9.9.KALSEC INC.

9.9.1.Company overview

9.9.2.Key Executives

9.9.3.Company snapshot

9.9.4.Operating business segments

9.9.5.Product portfolio

9.10.KONINKLIJKE DSM N.V.

9.10.1.Company overview

9.10.2.Key executive

9.10.3.Company snapshot

9.10.4.Operating business segments

9.10.5.Product portfolio

9.10.6.R&D expenditure (Continued and discontinued operations)

9.10.7.Business performance (Continued and discontinued operations)

TABLE 01.GLOBAL LYCOPENE MARKET, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 02.GLOBAL POWDER LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)

TABLE 03.GLOBAL OTHERS LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)

TABLE 04.GLOBAL LYCOPENE MARKET, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 05.GLOBAL NATURAL LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)

TABLE 06.GLOBAL SYNTHETIC LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)

TABLE 07.GLOBAL LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 08.GLOBAL LYCOPENE MARKET FOR FOOD AND BEVERAGE INDUSTRY, BY REGION, 2020–2030 ($ THOUSAND)

TABLE 09.GLOBAL LYCOPENE MARKET FOR NUTRACEUTICALS AND PHARMACEUTICALS INDUSTRY, BY REGION, 2020–2030 ($ THOUSAND)

TABLE 10.GLOBAL LYCOPENE FOR COSMETICS AND PERSONAL CARE INDUSTRY, BY REGION, 2020–2030 ($ THOUSAND)

TABLE 11.GLOBAL LYCOPENE MARKET, BY REGION, 2020–2030 ($ THOUSAND)

TABLE 12.NORTH AMERICA LYCOPENE MARKET VALUE, BY FORM 2020–2030 ($ THOUSAND)

TABLE 13.NORTH AMERICA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 14.NORTH AMERICA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 15.NORTH AMERICA LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ THOUSAND)

TABLE 16.U.S. LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 17.U.S. LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 18.U.S. LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 19.CANADA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 20.CANADA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 21.CANADA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 22.MEXICO LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 23.MEXICO LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 24.MEXICO LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 25.EUROPE LYCOPENE MARKET VALUE, BY FORM 2020–2030 ($ THOUSAND)

TABLE 26.EUROPE LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 27.EUROPE LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 28.EUROPE LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ THOUSAND)

TABLE 29.UK LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 30.UK LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 31.UK LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 32.GERMANY LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 33.GERMANY LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 34.GERMANY LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 35.FRANCE LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 36.FRANCE LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 37.FRANCE LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 38.ITALY LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 39.ITALY LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 40.ITALY LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 41.SPAIN LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 42.SPAIN LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 43.SPAIN LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 44.REST OF EUROPE LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 45.REST OF EUROPE LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 46.REST OF EUROPE LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 47.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY FORM 2020–2030 ($ THOUSAND)

TABLE 48.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 49.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 50.ASIA-PACIFIC LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ THOUSAND)

TABLE 51.CHINA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 52.CHINA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 53.CHINA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 54.JAPAN LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 55.JAPAN LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 56.JAPAN LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 57.INDIA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 58.INDIA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 59.INDIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 60.ASEAN LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 61.ASEAN LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 62.ASEAN LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 63.AUSTRALIA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 64.AUSTRALIA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 65.AUSTRALIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 66.SOUTH KOREA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 67.SOUTH KOREA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 68.SOUTH KOREA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 69.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 70.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 71.REST OF ASIA-PACIFIC LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 72.LAMEA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 73.LAMEA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 74.LAMEA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 75.LAMEA LYCOPENE MARKET VALUE, BY COUNTRY, 2020–2030 ($ MILLION)

TABLE 76.BRAZIL LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 77.BRAZIL LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 78.BRAZIL LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 79.ARGENTINA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 80.ARGENTINA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 81.ARGENTINA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 82.SAUDI ARABIA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 83.SAUDI ARABIA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 84.SAUDI ARABIA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 85.SOUTH AFRICA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 86.SOUTH AFRICA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 87.SOUTH AFRICA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 88.REST OF LAMEA LYCOPENE MARKET VALUE, BY FORM, 2020–2030 ($ THOUSAND)

TABLE 89.REST OF LAMEA LYCOPENE MARKET VALUE, BY NATURE, 2020–2030 ($ THOUSAND)

TABLE 90.REST OF LAMEA LYCOPENE MARKET VALUE, BY APPLICATION, 2020–2030 ($ THOUSAND)

TABLE 91.ALLIED BIOTECH CORPORATION: COMPANY SNAPSHOT

TABLE 92.ALLIED BIOTECH CORPORATION: OPERATING SEGMENTS

TABLE 93.ALLIED BIOTECH CORPORATION: PRODUCT PORTFOLIO

TABLE 94.ARCHER DANIELS MIDLAND COMPANY: KEY EXECUTIVE

TABLE 95.ARCHER DANIELS MIDLAND COMPANY: COMPANY SNAPSHOT

TABLE 96.ARCHER DANIELS MIDLAND COMPANY: OPERATING SEGMENTS

TABLE 97.ARCHER DANIELS MIDLAND COMPANY: PRODUCT PORTFOLIO

TABLE 98.ARCHER DANIELS MIDLAND COMPANY: R&D EXPENDITURE, 2018-2020 ($MILLION)

TABLE 99.ARCHER DANIELS MIDLAND COMPANY: NET SALES, 2018-2020 ($MILLION)

TABLE 100.AROMATAGROUP SRL: KEY EXECUTIVES

TABLE 101.AROMATAGROUP SRL: COMPANY SNAPSHOT

TABLE 102.AROMATAGROUP SRL: OPERATING SEGMENTS

TABLE 103.AROMATAGROUP SRL: PRODUCT PORTFOLIO

TABLE 104.BASF SE: KEY EXECUTIVES

TABLE 105.BASF SE: COMPANY SNAPSHOT

TABLE 106.BASF SE: OPERATING SEGMENTS

TABLE 107.BASF SE: PRODUCT PORTFOLIO

TABLE 108.BASF SE: NET SALES, 2018-2020 ($MILLION)

TABLE 109.DIVIS LABORATORIES LTD.: KEY EXECUTIVES

TABLE 110.DIVIS LABORATORIES LTD.: COMPANY SNAPSHOT

TABLE 111.DIVIS LABORATORIES LTD.: OPERATING SEGMENTS

TABLE 112.DIVIS LABORATORIES LTD.: PRODUCT PORTFOLIO

TABLE 113.DIVIS LABORATORIES LTD.: NET SALES, 2017–2019 ($MILLION)

TABLE 114.DOEHLER GROUP SE: KEY EXECUTIVES

TABLE 115.DOEHLER GROUP SE: COMPANY SNAPSHOT

TABLE 116.DOEHLER GROUP SE: OPERATING SEGMENTS

TABLE 117.DOEHLER GROUP SE: PRODUCT PORTFOLIO

TABLE 118.EXCELVITE: KEY EXECUTIVES

TABLE 119.EXCELVITE: COMPANY SNAPSHOT

TABLE 120.EXCELVITE: OPERATING SEGMENTS

TABLE 121.EXCELVITE: PRODUCT PORTFOLIO

TABLE 122.GIVAUDANINTERNATIONAL SA: KEY EXECUTIVE

TABLE 123.GIVAUDANINTERNATIONAL SA: COMPANY SNAPSHOT

TABLE 124.GIVAUDANINTERNATIONAL SA: OPERATING SEGMENTS

TABLE 125.GIVAUDANINTERNATIONAL SA: PRODUCT PORTFOLIO

TABLE 126.GIVAUDANINTERNATIONAL SA: R&D EXPENDITURE, 2018-2020 ($MILLION)

TABLE 127.GIVAUDANINTERNATIONAL SA: NET SALES, 2018-2020 ($MILLION)

TABLE 128.KALSEC INC: KEY EXECUTIVES

TABLE 129.KALSEC INC: COMPANY SNAPSHOT

TABLE 130.KALSEC INC: OPERATING SEGMENTS

TABLE 131.KALSEC INC: PRODUCT PORTFOLIO

TABLE 132.KONINKLIJKE DSM N.V.: KEY EXECUTIVE

TABLE 133.KONINKLIJKE DSM N.V.: COMPANY SNAPSHOT

TABLE 134.KONINKLIJKE DSM N.V.: OPERATING SEGMENTS

TABLE 135.KONINKLIJKE DSM N.V.: PRODUCT PORTFOLIO

TABLE 136.KONINKLIJKE DSM N.V.: R&D EXPENDITURE, 2018-2020 ($MILLION)

TABLE 137.KONINKLIJKE DSM N.V.: NET SALES, 2018-2020 ($MILLION)